Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net earnings/(loss)	$ 497	$ (4,350)
Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:
Depreciation and amortization	603	688
Impairments and (gain)/loss on disposal of assets, net	78	7
Loss on Extinguishment of Debt	1	9
Share-based compensation	84	68
Provision for bad debts	49	86
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
Increase in trade receivables	(511)	(653)
Increase in inventories	(1,323)	(8)
Increase in accounts payable	1,267	448
Other accrued liabilities and operating items, net	1,019	5,425
Net cash provided by operating activities	1,764	1,720
Cash flows from investing activities:
Acquisition of subsidiaries, net of cash acquired	(3)	0
Additions to property and equipment	(274)	(239)
Purchase of investments	(18)	(18)
Proceeds from investments	5	6
Proceeds from divestitures and disposal of property and equipment and held for sale assets	0	2
Net cash used in investing activities	(290)	(249)
Cash flows from financing activities:
Net change in short-term borrowings	0	(2)
Payments for (Proceeds from) Hedge, Financing Activities	18	0
Reduction of long-term obligations	(53)	(888)
Net proceeds/(tax withholdings) from share-based compensation	(1)	(4)
Dividends on common shares	(432)	(428)
Payments for Repurchase of Common Stock	(200)	(350)
Net cash used in financing activities	(668)	(1,672)
Effect of exchange rates changes on cash and equivalents	8	(1)
Cash Reclassified to Asset Held for Sale	(86)	0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	728	(202)
Cash and equivalents at beginning of period	2,771	2,531
Cash and equivalents at end of period	$ 3,499	$ 2,329